Statistics for Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy

Total visits

views
Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy 138

Total visits per month

views
September 2023 0
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0

File Visits

views
Wanandy_Pharmaceutical_AM2019.pdf(legacy) 23
Wanandy_Pharmaceutical_Supp_AM2019.pdf 8
Wanandy_Pharmaceutical_AM2019.pdf 6
Wanandy_Pharmaceutical_Supp_AM2019.pdf(legacy) 2